Peter Openshaw

Professor Peter Openshaw

#VaccinesWork. But only if everyone can access them.

That's why, @peteropenshaw.bsky.social, Co-Director of @hicvac.bsky.social, is advancing the use of human challenge studies to help develop next-generation #vaccines in LMICs.

Discover his work, this #WIW2025 👉 www.imperial.ac.uk/Stories/the-...

Expert Warns H5N1 Bird Flu Could Trigger the Next Global Pandemic - The Daily Intake H5N1 has infected millions of birds globally and crossed into mammals, including some human cases, raising concerns about its potential evolution.

thedailyintake.online/2025/03/01/e...

With #PubMed being down, it’s worth reminding ourselves that European alternatives exist:

🔗 europepmc.org
🔗 www.ebi.ac.uk/ena/browser/...
🔗 www.ensembl.org

Deadly outbreak of unidentified disease in western Congo surpasses 1000 cases Health authorities have yet to identify the cause of outbreaks of a disease in the Democratic Republic of Congo that the World Health Organization has called “a significant public health threat.” Las...

www.bmj.com/content/388/...

Science Feed Rules: 🧪 No misinformation 🧪 Keep posts relevant to science 🧪 Use alt text 🧪 Credit images 🧪 Give context to links to external sites 🧪 Have fun!

Welcome to the Science feed!

Please read our FAQs for instructions for how to be added as a contributor: bossett.io/science-feed/

Mod introductory posts linked below⬇️

Use the test tube emoji on posts you want to appear in the feed🧪

Please like the feed and make sure you follow our feed rules:

Personalising risk from COVID-19 key to protecting immunosuppressed people | Imperial News | Imperial College London New research underscores the need for ongoing COVID-19 protection for people with weakened immune systems.

Personalising risk from COVID-19
'Research, published @thelancet.bsky.social, reveals how a simple blood test can predict the severity of COVID-19 infection, paving the way for personalised approaches to vaccination and better protection for those most at risk.'
www.imperial.ac.uk/news/260173/...

#RSVvaccines have recently been made available, Stefania Maggi explains what vaccines & where

🎧 Tune into #ESWIAirborne on the history, challenges, and triumphs of #RSV vaccine development

@peteropenshaw.bsky.social

shorturl.at/bVI70

#ESWIEducationHub

Variants and vaccines impact nasal immunity over three waves of SARS-CoV-2 Nature Immunology - Ordovas-Montanes and colleagues describe the composition of the nasal cellular ecosystem and signatures of disease severity in vaccinated and unvaccinated adults during...

Variants and vaccines impact nasal immunity over three waves of SARS-CoV-2

The nasal immune response is altered by previous vaccination and variant encounter.

www.nature.com/artic...
1/3

Trump hits NIH with ‘devastating’ freezes on meetings, travel, communications, and hiring Researchers facing

Donald Trump making US science great again. 🤦🏻‍♂️ www.science.org/content/arti...

I'm Chairing the the José Antonio Melero Early Career Investigator Award lecture by Ryan Thwaites on March 12th at #RSV2025, #Brazil: rsv2025.org. Jose and I were the only people to attend every RSV symposium since 1996- he was a wonderful colleague and a great scientist.

‘Grave concern’ over drop in NHS clinical researchers.

The declining number of clinical academics in the National Health Service is “of grave concern”, according to the author of a recent report on the NHS.

www.researchprofessionalnews.com/rr-news-uk-c...